Home » US FDA Guidance Specifies SNIs to Authenticate Drug Packages
US FDA Guidance Specifies SNIs to Authenticate Drug Packages
April 15, 2010
Drugmakers will have more leeway for serial numbers on packaging that would help authenticate prescription drugs in the supply chain, according to the
U.S. Food and Drug Administration’s (FDA) first final guidance on standardized numerical identifiers (SNIs).
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor